219 related articles for article (PubMed ID: 20400883)
1. Increased risk of myocardial infarction in HIV-infected patients in France, relative to the general population.
Lang S; Mary-Krause M; Cotte L; Gilquin J; Partisani M; Simon A; Boccara F; Bingham A; Costagliola D;
AIDS; 2010 May; 24(8):1228-30. PubMed ID: 20400883
[TBL] [Abstract][Full Text] [Related]
2. Impact of individual antiretroviral drugs on the risk of myocardial infarction in human immunodeficiency virus-infected patients: a case-control study nested within the French Hospital Database on HIV ANRS cohort CO4.
Lang S; Mary-Krause M; Cotte L; Gilquin J; Partisani M; Simon A; Boccara F; Costagliola D;
Arch Intern Med; 2010 Jul; 170(14):1228-38. PubMed ID: 20660842
[TBL] [Abstract][Full Text] [Related]
3. Influence of control selection in nested case-control studies: the example of exposure to antiretroviral treatment (ART) and the risk of myocardial infarction (MI) in the French Hospital Database on HIV (FHDH-ANRS CO4).
Guiguet M; Mary-Krause M; Ename B; Costagliola D; Grabar S
Pharmacoepidemiol Drug Saf; 2008 May; 17(5):468-74. PubMed ID: 18324608
[TBL] [Abstract][Full Text] [Related]
4. Increased risk of myocardial infarction with duration of protease inhibitor therapy in HIV-infected men.
Mary-Krause M; Cotte L; Simon A; Partisani M; Costagliola D;
AIDS; 2003 Nov; 17(17):2479-86. PubMed ID: 14600519
[TBL] [Abstract][Full Text] [Related]
5. Risk of AIDS-defining cancers among HIV-1-infected patients in France between 1992 and 2009: results from the FHDH-ANRS CO4 cohort.
Hleyhel M; Belot A; Bouvier AM; Tattevin P; Pacanowski J; Genet P; De Castro N; Berger JL; Dupont C; Lavolé A; Pradier C; Salmon D; Simon A; Martinez V; Costagliola D; Grabar S;
Clin Infect Dis; 2013 Dec; 57(11):1638-47. PubMed ID: 23899679
[TBL] [Abstract][Full Text] [Related]
6. Class of antiretroviral drugs and the risk of myocardial infarction.
; Friis-Møller N; Reiss P; Sabin CA; Weber R; Monforte Ad; El-Sadr W; Thiébaut R; De Wit S; Kirk O; Fontas E; Law MG; Phillips A; Lundgren JD
N Engl J Med; 2007 Apr; 356(17):1723-35. PubMed ID: 17460226
[TBL] [Abstract][Full Text] [Related]
7. Protease inhibitors and cardiovascular outcomes in patients with HIV-1.
Holmberg SD; Moorman AC; Williamson JM; Tong TC; Ward DJ; Wood KC; Greenberg AE; Janssen RS;
Lancet; 2002 Nov; 360(9347):1747-8. PubMed ID: 12480430
[TBL] [Abstract][Full Text] [Related]
8. Incidence of myocardial infarctions in HIV-infected patients between 1983 and 1998: the Frankfurt HIV-cohort study.
Rickerts V; Brodt H; Staszewski S; Stille W
Eur J Med Res; 2000 Aug; 5(8):329-33. PubMed ID: 10958765
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the risks of atherosclerotic events versus death from other causes associated with antiretroviral use.
Kwong GP; Ghani AC; Rode RA; Bartley LM; Cowling BJ; da Silva B; Donnelly CA; van Sighem AI; Cameron DW; Danner SA; de Wolf F; Anderson RM
AIDS; 2006 Oct; 20(15):1941-50. PubMed ID: 16988515
[TBL] [Abstract][Full Text] [Related]
10. Combination antiretroviral therapy and the risk of myocardial infarction.
Friis-Møller N; Sabin CA; Weber R; d'Arminio Monforte A; El-Sadr WM; Reiss P; Thiébaut R; Morfeldt L; De Wit S; Pradier C; Calvo G; Law MG; Kirk O; Phillips AN; Lundgren JD;
N Engl J Med; 2003 Nov; 349(21):1993-2003. PubMed ID: 14627784
[TBL] [Abstract][Full Text] [Related]
11. Increased risk of abdominal wall hernia associated with combination anti-retroviral therapy in HIV-infected patients-results from a Swedish cohort-study.
Sundström A; Mortimer O; Akerlund B; Karlsson A; Flamholc L; Håkangård C; Granholm H; Persson I; Morfeldt L
Pharmacoepidemiol Drug Saf; 2010 May; 19(5):465-73. PubMed ID: 20186997
[TBL] [Abstract][Full Text] [Related]
12. The use of the Framingham equation to predict myocardial infarctions in HIV-infected patients: comparison with observed events in the D:A:D Study.
Law MG; Friis-Møller N; El-Sadr WM; Weber R; Reiss P; D'Arminio Monforte A; Thiébaut R; Morfeldt L; De Wit S; Pradier C; Calvo G; Kirk O; Sabin CA; Phillips AN; Lundgren JD;
HIV Med; 2006 May; 7(4):218-30. PubMed ID: 16630034
[TBL] [Abstract][Full Text] [Related]
13. Human immunodeficiency virus type 1 incidence among blood donors in France, 1992 through 2006: use of an immunoassay to identify recent infections.
Pillonel J; Barin F; Laperche S; Bernillon P; Le Vu S; Brunet S; Thierry D; Desenclos JC;
Transfusion; 2008 Aug; 48(8):1567-75. PubMed ID: 18482193
[TBL] [Abstract][Full Text] [Related]
14. Incidence of risk factors for myocardial infarction and other vascular diseases in patients with psoriasis.
Kaye JA; Li L; Jick SS
Br J Dermatol; 2008 Sep; 159(4):895-902. PubMed ID: 18616778
[TBL] [Abstract][Full Text] [Related]
15. Risk of myocardial infarction in patients with HIV infection exposed to specific individual antiretroviral drugs from the 3 major drug classes: the data collection on adverse events of anti-HIV drugs (D:A:D) study.
Worm SW; Sabin C; Weber R; Reiss P; El-Sadr W; Dabis F; De Wit S; Law M; Monforte AD; Friis-Møller N; Kirk O; Fontas E; Weller I; Phillips A; Lundgren J
J Infect Dis; 2010 Feb; 201(3):318-30. PubMed ID: 20039804
[TBL] [Abstract][Full Text] [Related]
16. Cohort Profile: French hospital database on HIV (FHDH-ANRS CO4).
Mary-Krause M; Grabar S; Lièvre L; Abgrall S; Billaud E; Boué F; Boyer L; Cabié A; Cotte L; De Truchis P; Duval X; Duvivier C; Enel P; Gasnault J; Gaud C; Gilquin J; Guiguet M; Katlama C; Khuong-Josses MA; Lacombe JM; Lang S; Lascaux AS; Launay O; Mahamat A; Matheron S; Meynard JL; Pavie J; Pilorgé F; Piroth L; Poizot-Martin I; Potard V; Pradier C; Reynes J; Rouveix E; Selinger-Leneman H; Simon A; Tattevin P; Tissot-Dupont H; Viard JP; Viget N; Costagliola D
Int J Epidemiol; 2014 Oct; 43(5):1425-36. PubMed ID: 24550249
[TBL] [Abstract][Full Text] [Related]
17. Incidence rate and risk factors for loss to follow-up in HIV-infected patients from five French clinical centres in Northern France - January 1997 to December 2006.
Ndiaye B; Ould-Kaci K; Salleron J; Bataille P; Bonnevie F; Choisy P; Cochonat K; Fontier C; Guerroumi H; Ajana F; Chaud P; Yazdanpanah Y
Antivir Ther; 2009; 14(4):567-75. PubMed ID: 19578242
[TBL] [Abstract][Full Text] [Related]
18. Invasive cervical cancer in HIV-infected women: risk and survival relative to those of the general population in France. Results from the French Hospital Database on HIV (FHDH)-Agence Nationale de Recherches sur le SIDA et les Hépatites Virales (ANRS) CO4 cohort study.
Grabar S; Hleyhel M; Belot A; Bouvier AM; Tattevin P; Pacanowski J; Genet P; Pradier C; Salmon D; Simon A; Pourcher V; Spano JP; Poizot-Martin I; Costagliola D
HIV Med; 2019 Mar; 20(3):222-229. PubMed ID: 30693646
[TBL] [Abstract][Full Text] [Related]
19. Symptomatic bone disorders in HIV-infected patients: incidence in the Aquitaine cohort (1999-2002).
Martin K; Lawson-Ayayi S; Miremont-Salamé G; Blaizeau MJ; Balestre E; Lacoste D; Ragnaud JM; Malvy D; Dupon M; Mercié P; Schaeverbeke T; Haramburu F; Dabis F;
HIV Med; 2004 Nov; 5(6):421-6. PubMed ID: 15544694
[TBL] [Abstract][Full Text] [Related]
20. Incidence rate and risk factors for loss to follow-up in a French clinical cohort of HIV-infected patients from January 1985 to January 1998.
Lebouché B; Yazdanpanah Y; Gérard Y; Sissoko D; Ajana F; Alcaraz I; Boitte P; Cadoré B; Mouton Y
HIV Med; 2006 Apr; 7(3):140-5. PubMed ID: 16494627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
